Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 173

1.

Cyclo-oxygenase-2 inhibition increases blood pressure in rats.

Höcherl K, Endemann D, Kammerl MC, Grobecker HF, Kurtz A.

Br J Pharmacol. 2002 Aug;136(8):1117-26.

2.

Role of prostanoids in regulation of the renin-angiotensin-aldosterone system by salt intake.

Höcherl K, Kammerl MC, Schumacher K, Endemann D, Grobecker HF, Kurtz A.

Am J Physiol Renal Physiol. 2002 Aug;283(2):F294-301.

3.

Angiotensin II feedback is a regulator of renocortical renin, COX-2, and nNOS expression.

Kammerl MC, Richthammer W, Kurtz A, Krämer BK.

Am J Physiol Regul Integr Comp Physiol. 2002 Jun;282(6):R1613-7.

4.

Inhibition of cyclooxygenase-2 attenuates urinary prostanoid excretion without affecting renal renin expression.

Kammerl MC, Nüsing RM, Seyberth HW, Riegger GA, Kurtz A, Krämer BK.

Pflugers Arch. 2001 Sep;442(6):842-7.

PMID:
11680616
5.

Effect of felodipine on blood pressure, body sodium, plasma renin activity and plasma aldosterone in hypertensive and normotensive rats.

Ledingham JM, Hamada M, Simpson FO.

Clin Exp Pharmacol Physiol Suppl. 1995 Dec;22(1):S323-5.

PMID:
9072412
6.

Dietary salt excess unmasks blunted aldosterone suppression and sodium retention in the stroke-prone phenotype of the spontaneously hypertensive rat.

Volpe M, Rubattu S, Ganten D, Enea I, Russo R, Lembo G, Mirante A, Condorelli G, Trimarco B.

J Hypertens. 1993 Aug;11(8):793-8.

PMID:
8228202
7.

Adverse interactions of rofecoxib with lisinopril in spontaneously hypertensive rats.

Dubey K, Balani DK, Tripathi CB, Singh R, Bajaj R, Pillai KK.

Clin Toxicol (Phila). 2005;43(5):361-73.

PMID:
16235511
8.

Influence of different dietary salts on the cardiovascular and renal effects of moxonidine in spontaneously hypertensive rats.

Mervaala EM, Malmberg L, Teräväinen TL, Lähteenmäki T, Karjala K, Paakkari I, Pörsti I, Mest HJ, Vapaatalo H, Karppanen H.

Naunyn Schmiedebergs Arch Pharmacol. 1997 Jul;356(1):107-14.

PMID:
9228197
9.

Influence of dietary salts on the cardiovascular effects of low-dose combination of ramipril and felodipine in spontaneously hypertensive rats.

Mervaala EM, Malmberg L, Teräväinen TL, Laakso J, Vapaatalo H, Karppanen H.

Br J Pharmacol. 1998 Jan;123(2):195-204.

10.

Blood pressure responses to sucrose ingestion in four rat strains.

Preuss HG, el Zein M, Knapka J, MacArthy P, Yousufi AK, Gleim GW, Glace B, Zukowska-Grojec Z.

Am J Hypertens. 1992 Apr;5(4 Pt 1):244-50.

PMID:
1599637
11.
12.

Salt appetite, body sodium, handling of a NaCl load, renin, and aldosterone in genetically and spontaneously hypertensive rats.

Ledingham JM, Simpson FO, Hamada M.

J Cardiovasc Pharmacol. 1990;16 Suppl 7:S6-8. Review.

PMID:
1708028
13.

Tempol or candesartan prevents high-fat diet-induced hypertension and renal damage in spontaneously hypertensive rats.

Chung S, Park CW, Shin SJ, Lim JH, Chung HW, Youn DY, Kim HW, Kim BS, Lee JH, Kim GH, Chang YS.

Nephrol Dial Transplant. 2010 Feb;25(2):389-99. doi: 10.1093/ndt/gfp472. Epub 2009 Sep 11.

14.
15.

Role of renal nerves in stimulation of renin, COX-2, and nNOS in rat renal cortex during salt deficiency.

Höcherl K, Kammerl M, Kees F, Krämer BK, Grobecker HF, Kurtz A.

Am J Physiol Renal Physiol. 2002 Mar;282(3):F478-84.

16.

Effects of ACE inhibition on cyclosporine A-induced hypertension and nephrotoxicity in spontaneously hypertensive rats on a high-sodium diet.

Mervaala E, Lassila M, Vaskonen T, Krogerus L, Lähteenmäki T, Vapaatalo H, Karppanen H.

Blood Press. 1999;8(1):49-56.

PMID:
10412883
17.

Comparison of rofecoxib, celecoxib, and naproxen on renal function in elderly subjects receiving a normal-salt diet.

Schwartz JI, Vandormael K, Malice MP, Kalyani RN, Lasseter KC, Holmes GB, Gertz BJ, Gottesdiener KM, Laurenzi M, Redfern KJ, Brune K.

Clin Pharmacol Ther. 2002 Jul;72(1):50-61.

PMID:
12152004
18.

Early co-expression of cyclooxygenase-2 and renin in the rat kidney cortex contributes to the development of N(G)-nitro-L-arginine methyl ester induced hypertension.

Guzmán-Hernández EA, Villalobos-Molina R, Sánchez-Mendoza MA, Del Valle-Mondragón L, Pastelín-Hernández G, Ibarra-Barajas M.

Can J Physiol Pharmacol. 2015 Apr;93(4):299-308. doi: 10.1139/cjpp-2014-0347. Epub 2015 Jan 26.

PMID:
25761067
19.

Effect of rofecoxib on antihypertensive effects of candesartan in experimental models of hypertension.

Jain S, Gupta M, Malhotra S, Pandhi P.

Methods Find Exp Clin Pharmacol. 2005 Jan-Feb;27(1):11-6.

PMID:
15834454
20.
Items per page

Supplemental Content

Write to the Help Desk